|
Volumn 12, Issue SUPPL. 1, 2008, Pages
|
Clinical study of cinacalcet in Japan
|
Author keywords
Adverse events; Calcium phosphorus products; Cinacalcet hydrochloride; Parathyroid hormone; Secondary hyperparathyroidism
|
Indexed keywords
CALCIUM;
CINACALCET;
PARATHYROID HORMONE;
PHOSPHATE BINDING AGENT;
PHOSPHORUS;
PLACEBO;
VITAMIN D;
ABDOMINAL DISTENSION;
ANOREXIA;
CALCIUM BLOOD LEVEL;
CLINICAL TRIAL;
CONFERENCE PAPER;
DOSE RESPONSE;
HEMODIALYSIS;
HUMAN;
HYPOCALCEMIA;
INCIDENCE;
NAUSEA AND VOMITING;
PARATHYROID HORMONE BLOOD LEVEL;
PRIORITY JOURNAL;
QT PROLONGATION;
SECONDARY HYPERPARATHYROIDISM;
SIDE EFFECT;
STOMACH DISCOMFORT;
ASIAN CONTINENTAL ANCESTRY GROUP;
CLINICAL TRIALS, PHASE II AS TOPIC;
CLINICAL TRIALS, PHASE III AS TOPIC;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG APPROVAL;
HUMANS;
HYPERPARATHYROIDISM, SECONDARY;
JAPAN;
LONGITUDINAL STUDIES;
NAPHTHALENES;
RENAL DIALYSIS;
|
EID: 54949083459
PISSN: 17449979
EISSN: 17449987
Source Type: Journal
DOI: 10.1111/j.1744-9987.2008.00625.x Document Type: Conference Paper |
Times cited : (4)
|
References (4)
|